Replies to post #445827 on Anavex Life Sciences Corp (AVXL)

[12x]

Everything Anavex now has is the EMA submission, which in my view was speculative and unrealistic

Care to elaborate?

Anavex might feel unlucky in picking the endpoints. Had the endpoints been ADAS-COg and CDR-SB instead of ADCS-ADL, it would be a total success and $250 SP. So from shareholder and management standpoint, it’s responsible thing to do - to submit the application.